PRESENTATION TITLE: 

A CASE OF ACRAL MELANOMA 

PRESENTER(S): Hensin Tsao, MD, PhD

LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:

• Recognize the typical presentation, genetics, and risk factors such as trauma and mechanical stress.​
• Apply current melanoma staging criteria to acral melanoma cases and assess prognostic indicators, including tumor thickness, ulceration status, and sentinel lymph node biopsy results.​
• Evaluate the evidence supporting adjuvant immunotherapy in high-risk resected Stage IIB/C melanomas, including the benefits and risks of treatments such as pembrolizumab and nivolumab.

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.